Narrow search
Showing 1 - 10 of 524,507
Cover Image
An international drug administration : curing uncertainty in international pharmaceutical product liability
Davis, Katherine A. - In: Northwestern journal of international law & business 18 (1998) 4, pp. 685-729
Persistent link: https://www.econbiz.de/10001352075
Cover Image
The Challenge of Globalization in Pharmaceutical Law - Is an International Harmonization of Drug Approval Procedures Modeled after the European System Worth Considering?
Purnhagen, Kai P. - 2014
government's legislative powers. With trials and marketing of compounds and pharmaceuticals carried out in different countries …
Persistent link: https://www.econbiz.de/10014213862
Cover Image
Ausgestaltungsvarianten und ökonomische Konsequenzen einer 4. Hürde für die Erstattung von Arzneimitteln
Sundmacher, Torsten; Jasper, Jörg - In: Zeitschrift für Wirtschaftspolitik 55 (2006) 1, pp. 92-124
Persistent link: https://www.econbiz.de/10003308997
Cover Image
Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy
Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997
Persistent link: https://www.econbiz.de/10014633366
Cover Image
L ́Europe du médicament : politique, expertise, intérêts privés
Hauray, Boris - 2006
Persistent link: https://www.econbiz.de/10003317153
Cover Image
Ethics for drug testing in low and middle income countries : considerations for European market authorisation
Schipper, Irene; Weyzig, Francis - 2008
Persistent link: https://www.econbiz.de/10003797986
Cover Image
The national regulation of pharmaceutical markets and the timing of new drug launches in Europe
Heuer, Alexander (contributor); Mejer, Malwina (contributor) - 2007
, pharmaceutical companies, by acting strategically, may further increase launch delays. -- pharmaceuticals ; regulation ; new chemical …
Persistent link: https://www.econbiz.de/10003471161
Cover Image
Orphan Drugs : eine gesundheitsökonomische Analyse
Vorholt, Melanie - In: Steuerung des Gesundheitsverhaltens im Spannungsfeld …, (pp. 262-283). 2009
Persistent link: https://www.econbiz.de/10003909831
Cover Image
Ökonomische Begründungen für Pharmamarktregulierungen auf verschiedenen Kompetenzebenen : das Beispiel der Arzneimittel-Zulassungshürden in Europa
Cassel, Dieter; Müller, Christian; Sundmacher, Torsten - In: Zentralität und Dezentralität von Regulierung in …, (pp. 287-307). 2007
Persistent link: https://www.econbiz.de/10003502066